Although a substantial subset of patients exhibits suboptimal metabolic responses to therapy, precise prevalence estimates of non-responders remain uncertain, and no randomized controlled trials have demonstrated that microbiome-guided selection improves GLP-1 RA outcomes
We know that it increases the disease risk. Studies have linked weight cycling to cardiovascular disease and diabetes, among other health issues
Clinical research has extended this concept by evaluating cagrilintide-semaglutide treatment in adults with overweight or obesity and type 2 diabetes, providing evidence that combined pathway engagement can improve both weight-related and glycemic outcomes [6]
But regardless of the weight loss, I am no longer pre diabetic
Helping your body tap into fat stores can preserve glycogen for later in the race
Autoimmune diseases, particularly Graves disease, are one of the primary causes